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ABSTRACT
The p53 tetramer recognizes specifically a 20-bp
DNA element. Here, we examined symmetries
encoded in p53 response elements (p53REs). We
analyzed base inversion correlations within the half-
site, as well as in the full-site palindrome. We found
that p53REs are not only direct repeats of half-sites;
rather, two p53 half-sites couple to form a higher
order 20bp palindrome. The palindrome couplings
between the half-sites are stronger for the human
than for the mouse genome. The full-site palin-
drome and half-site palindrome are controlled by
insertions between the two half-sites. The most
notable feature is that the full-site palindrome with
coupling between quarter-sites one and four (H14
coupling) dominates the p53REs without insertions.
The most frequently observed insertion in human
p53REs of 3bp enhances the half-site palindrome.
The statistical frequencies of the coupling between
the half-sites in the human genome correlate with
grouped experimental p53 affinities with p53REs.
Examination of known p53REs indicates the H14
couplings are stronger for positive regulation than
for negatively regulated p53REs, with repressors
having the lowest H14 couplings. We propose that
the palindromic sequence couplings may encode
such potential preferred multiple binding modes
of the p53 tetramer to DNA.
INTRODUCTION
p53 protein operates as a tumor suppressor and helps
regulate hundreds of genes in response to various types
of stress (1). DNA binding is critical for the biological
functions of p53. p53 can recognize speciﬁc DNA
sequences (2) or geometries (3). The sequence-speciﬁc
DNA binding mainly relates to the transcription function
of p53 to selectively bind its transcription targets. The p53
response element (p53RE) or p53-binding sites have two
half-site palindromes. While previously it was suggested
that the two palindromes may be consecutive or separated
by spacer with 1–14bp (2), one analysis (4) has indicated
that the lengths of the spacers between the two half-sites
are predominantly zero. The structure of p53 contains an
N-terminal transactivation domain, a DNA-binding core
domain, a C-terminal tetramerization and a regulatory
domain. Proper p53–DNA binding requires a well-folded
DNA-binding domain and a p53 homotetramer. The
monomeric p53–DNA interaction is well established (5),
and several possibilities for the p53 tetramer–DNA
interactions have been discussed (5–8).
Three conventional features are commonly used to
describe the p53RE: (1) the half-site palindrome has 10bp
with a consensus sequence of 50-RRRCWWGYYY-30,
where W can be A or T, and R and Y stand for purine and
pyrimidine bases, respectively. Thus, the half-site can be
described as two inverted repeats !  ; (2) the two half-
sites are highly repetitive; and (3) the symmetric nature of
p53RE decides the symmetric binding of the p53 tetramer.
In order to maintain genomic stability in response to
cellular stress, the p53 protein has to diﬀerentiate between
hundreds of p53RE to properly perform its functions (9).
The diﬀerentiation can be achieved by p53 concentra-
tion, location and target promoter sequences. Since the
consensus-binding site for p53 has been established (2),
many p53 target genes have been identiﬁed experimentally
(10–13). Computational algorithms were also developed
to explore the potential p53REs on genomic scale
(4,14–16). Currently, there are 4100 experimentally
veriﬁed p53RE sequences, with 542 high-probability p53
loci (4). The computationally identiﬁed p53RE sequences
are expected to be much larger. Thus, it is natural to
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tially recognized by p53.
One way to encode binding information is via symmetri-
cally structured DNA motifs (17). The internal symmetry
in the full-site is a typical feature of many natural p53REs
(18). The full-site p53REs may encode a direct repeat of
the half-sites or an inverted (palindromic) repeat of the
half-sites. There is evidence that proteins may use diﬀer-
ent oligomerization states to recognize DNA sequences
with diﬀerent symmetries. The p protein binds a DNA
sequence motif arranged in direct repeats or inverted
repeats using diﬀerent oligomerization surfaces (19,20).
T-box genes with various possible combinations also
selectively bind monomeric or dimeric transcriptional
factors (21). It appears that point mutations aﬀecting
the translation of direct repeats into inverted repeat
response element sequences may lead to a change in the
cooperativity of androgen receptor DNA binding (22,23).
Alternatively, geometric adaptation of a given oligomeric
state may accommodate the binding to alterations in the
DNA sequence symmetry. Thus, diﬀerent p53REs may
elicit diﬀerent p53-binding modes.
In this study, we systematically examined the symme-
tries encoded in p53REs. We focus on the correlated
base inversions within the half-site palindrome, as well
as within the full-site palindrome. Three datasets are
used, one compiled from known experimentally veriﬁed
sequences (see Appendix), and two from computationally
detected p53-responsive genes using p53MH (datasets of
mouse and human genomes, respectively) (14). We found
that the sequence of each p53RE is not a simple repeat
of its half-site. Rather, in addition, the two half-sites are
coupled to form a higher order palindrome of 20bp. The
base pair couplings between the two half-sites are stronger
for human genes than for mouse genes. When there is a
spacer between the half-sites, the level of coupling between
the quarter-sites as compared to that between the half-
sites depends on the size of the spacers.
METHODS
Dataset construction
The experimental dataset for p53REs is compiled from
four sources of references: (1) p53REs binding to tetra-
meric p53 construct (residues 94–360) (13); (2): Inga
et al.’s work focusing on the diﬀerential transactivation
by the p53 protein (10); (3) the group of p53 target genes
involved in speciﬁc p53 downstream eﬀects (11); and
(4) the dataset compiled and curated in the p53
knowledge-base (12). Redundant entries from these
sources are removed with 100 remaining p53RE sequences
(Appendix).
Datasets two and three are the mouse and human
p53RE sequences. These are downloaded from the web
site of p53MH (http://linkage.rockefeller.edu/p53/). The
putative p53 DNA-binding elements in 2583 human genes
have 25840 sequences and in the mouse there are 1713
homologous genes with 17378 sequences. These sequences
were detected by the p53MH algorithm by scanning
from the 50 to 30 end of each gene with an additional
10-kb nucleotide sequence appended at each end (14). The
p53MH algorithm has three basic elements: weighting,
scoring and ﬁltering, as described in detail in (14). Here,
we only used the putative p53REs detected in (14),
and removed a few entries with uncertain ‘N’ in the
sequences.
Two artiﬁcial random p53REs datasets are generated
by: (1) strictly following the p53 consensus binding site
sequence with: RRRCWWGYYY- RRRCWWGYYY.
The base in each position is randomly selected, as long
as it ﬁts the above consensus. For the second artiﬁcial
dataset, non-consensus bases are introduced into the
sequence randomly, however, with the overall percentage
exactly the same as that in the native p53REs (Table 1).
To generate the artiﬁcial p53RE dataset 2, four bins for
each position are set for A, T, C and G, respectively. The
bin size is identical to the number of counts in Table 1,
with a total count of 100. For example, for position one,
the A bin is 31 (from 1 to 31); 10 for T (from 32 to 41);
7 for C (from 42 to 48), and 52 for G (from 49 to 100).
A random number (ranging from 1 to 100) is generated
for each position. If the number is within the bin, the
corresponding base is selected.
Countof couplings in thesequences and datasets
The deﬁnitions of various symmetric elements of p53RE
are illustrated in Figure 1. We deﬁne three types of cou-
plings in p53RE to (1) compare the palindromes for half-
sites and for full-site; and (2) to quantitatively classify
the two half-sites of p53RE as direct repeats or inverted
repeats. For a given dataset, we count the total numbers
of the three types of couplings at each of the 20 positions
of the p53RE. The ﬁrst is Q-coupling to measure the
Table 1. Counts of bases appearing in the experimentally veriﬁed p53
response elements (sequences are listed in the Appendix)
Position A T C G
13 1 1 0 7 5 2
2 28 4 11 57
3 3 71 01 43 9
41 3 9 5 1
55 5 3 1 1 1 3
63 2 5 6 2 1 0
7 301 9 6
8 7 33 48 12
9 6 19 69 6
10 6 37 45 12
11 27 8 17 48
12 28 2 8 62
13 36 3 13 48
14 1 5 90 4
15 48 33 12 7
16 30 55 6 9
17 4 2 2 92
18 6 47 41 6
19 5 32 52 11
20 5 42 39 14
There are total 100 sequences listed in Appendix. Thus the counts
in this table are equivalent to percentage. The number of insertion
of spacers: Zero spacer: 55; one spacer: 8; two spacers: 8; three spacers:
7; four spacers; 3; ﬁve spacers: 3; six spacers: 5; eight spacers: 5;
10 spacers: 3; 11 spacers: 1; 13 spacers: 1; 14 spacers: 1.
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of inverted bases between Q1 and Q2, and between Q3
and Q4at the corresponding positions (i to 11 i, and
10þi to 21 i):
Q - coupling (iÞ¼Ni to ð11 iÞ or Nð10þiÞ to ð21 iÞ, i ¼ 1   5
1
where Ni to (11 i) is the total number of inverted base
pairs for the ﬁrst half-site (between Q1 and Q2at posi-
tions i and 11 i), and N(10þi) to (21 i) is the total number
of inverted base pairs for the second half-site (between
Q3 and Q4 at positions 10þi and 21 i), for all sequences
in a given dataset.
The second is the H-coupling between the two half-sites
to measure the full-site palindrome, by counting the
number of inverted bases between the two half-sites:
H-coupling ðiÞ¼Ni, ð21 iÞ, i ¼ 1   10 2
where Ni,(21 i) is the total number of inverted base
pairs. The H-coupling measures a correlation between
the ﬁrst half-site and the second half-site at positions i
and 21 i for all sequences in a given dataset. Higher
H-coupling implies that the p53REs in a dataset are
more likely to be inverted repeats (i.e. they are a full-site
palindrome).
The third element, T-coupling, measures direct repeats
by counting the number of identical bases at the respective
positions in the two half-sites:
T - coupling ðiÞ¼Ni, ð10þiÞ, i ¼ 1   10 3
where Ni, (10þi) is is the total number of identical base
pairs. T-coupling measures a correlation between the ﬁrst
half-site and the second half-site at positions i and 10þi
for all sequences in a given dataset.
For each p53RE sequence, the number of bases involved
in the Q-coupling, H-coupling and T-coupling are counted
according to the deﬁnitions in Equations (1)–(3), respec-
tively. The overall numbers of coupling counts in the
datasets are the summations of the individual counts of
coupled bases in each position in each sequence.
The overlapping bases simultaneously involved in the
Q-, H- and T-couplings are checked and removed prior
to the calculation of the coupling frequencies. Due to a
symmetrical relationship, a base is involved in all three
couplings as long as it is involved in any two of the three
couplings (Figure 1c). Therefore, the ﬁnal statistics of
the Q-, H- and T-couplings do not have overlapping
contributions.
Fractions of couplingand couplingmatrixes
The fraction of the bases involved in speciﬁc coupling
is calculated as follow:
Fqði, jÞ¼
Nqði, jÞ
NðjÞ
4
where Fq(i, j) is the fraction of Q-coupled base i at position
j; Nq(i, j) is the number of Q-coupled base i in position j;
H2 (half-site) H1 (half-site) H-Coupling (inverted bases between half-sites)
R1R2R3C4W5W6G7Y8Y9Y10 …...R1R2R3C4W5W6G7Y8Y9Y10
a Q-Coupling (inverted bases between quarter-sites)
Q1(quarter-site) Q2(quarter-site) Q3 (quarter-site) Q4 (quarter-site)
R1R2R3C4W5W6G7Y8Y9Y10 …...R1R2R3C4W5W6G7Y8Y9Y10
b
T-Coupling (identical bases between half sites)
T-only
H-only
Q-only
Q,H,T
c
Figure 1. Deﬁnition of symmetric couplings. (a) Q-coupling is deﬁned
by the number of inverted bases between Q1 and Q2, and between Q3
and Q4 at each palindrome position in the half-sites. H-coupling
measures the number of inverted bases between two half-sites at
corresponding palindrome positions. (b) T-coupling describes how
many bases are the same in respective positions in the two half-sites.
(c) Overlap of three couplings occurs as long as any two of the
Q-, H- or T-couplings overlap. The counts of overlapped couplings are
removed from the statistics of the contributions of various coupling.
Table 2. Fraction of bases involved in only H-coupling across the
half-sites for all potential human p53REs
Position Consensus A T C G Sum
1 A/G 0.158 0.016 0.008 0.087 0.270
2 A/G 0.135 0.005 0.002 0.175 0.319
3 A/G 0.130 0.007 0.006 0.152 0.297
4 C 000.002 0 0.003
5 A/T 0.186 0.157 0.000 0 0.344
6 A/T 0.151 0.187 0 0 0.339
7 G 0000.003 0.003
8 T/C 0 0.128 0.165 0.007 0.303
9 T/C 0.006 0.139 0.121 0.003 0.271
10 T/C 0.017 0.122 0.083 0.007 0.232
11 A/G 0.122 0.017 0.007 0.083 0.232
12 A/G 0.139 0.006 0.003 0.121 0.271
13 A/G 0.128 0 0.007 0.165 0.302
14 C 0 0 0.003 0 0.003
15 A/T 0.187 0.151 0 0 0.339
16 A/T 0.157 0.186 0 0.000 0.344
17 G 0000.002 0.003
18 T/C 0.007 0.130 0.152 0.006 0.297
19 T/C 0.005 0.135 0.175 0.002 0.319
20 T/C 0.016 0.158 0.087 0.008 0.271
Bold fonts are for consensus bases.
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the dataset (total number of sequences). Similarly, the
fractions of H-coupled base Fh(i, j) and T-coupled base
Fq(i, j) are calculated (Table 2).
In the case of dividing the dataset into subgroups
according to the number of inserted base pairs between the
half-sites, N(j) refers to the total number of sequences in
the subgroup (Table 3). Thus, a coupling matrix is deﬁned
by the fraction of a given base in a given position that
is involved in the Q-coupling, H-coupling and T-coupling,
respectively. In all of the above calculations, bases
with overlapped Q-, H- and T-couplings are not counted.
Table 3 reports the coupling matrices for the p53REs
without insertion.
Evaluation of sequence-dependent quarter-site couplings
For a given sequence, the couplings of two quarter-sites
are evaluated by adding the fractions of the coupling
of the bases in all positions within the coupled quarter-
sites. The weights of ﬁve correlation modes are evaluated
as the sum of their corresponding quarter-site frequency
matrix:
(1) T13 mode with T-coupling matrix, sum of fraction:
FT13 ¼
X
MTðQ1Þþ
X
MTðQ3Þ;
(2) T24 mode with T-coupling matrix, sum of fraction:
FT24 ¼
X
MTðQ2Þþ
X
MTðQ4Þ;
(3) H14 mode with H-coupling matrix, sum of fraction:
FH14 ¼
X
MHðQ1Þþ
X
MHðQ4Þ;
(4) H23 model with H-coupling matrix, sum of fraction:
FH23 ¼
X
MHðQ2Þþ
X
MHðQ3Þ;
(5) The Q1234 mode with Q-coupling matrix, sum of
fraction:
FQ1234 ¼
P
MQðQ1Þþ
P
MQðQ2Þ
þ
P
MQðQ3Þþ
P
MQðQ4Þ
  
2
:
Here, the weight is scaled to be comparable with the
other four modes where only two quarter-sites are
evaluated. Finally, the probabilities or the populations
of a quarter-site coupling mode are normalized as:
PT13 ¼
FT13
FT13 þ FT24 þ FH14 þ FH23 þ FQ1234
, 5
PT24 ¼
FT24
FT13 þ FT24 þ FH14 þ FH23 þ FQ1234
, 6
PH14 ¼
FH14
FT13 þ FT24 þ FH14 þ FH23 þ FQ1234
, 7
PH23 ¼
FH23
FT13 þ FT24 þ FH14 þ FH23 þ FQ1234
, 8
PQ1234 ¼
FQ1234
FT13 þ FT24 þ FH14 þ FH23 þ FQ1234
: 9
Table 3. Fraction of bases involved in various couplings for potential human p53REs without a spacer (insertion) between the two half-sites
H-coupling only T-coupling only Q-coupling only
No Con A T C G Sum ATCGATCG
1 A/G 0.245 0.006 0.005 0.068 0.323 0.086 0.012 0.009 0.178 0.104 0.009 0.006 0.066
2 A/G 0.095 0.004 0.003 0.492 0.594 0.090 0.005 0.001 0.096 0.097 0.006 0.004 0.086
3 A/G 0.089 0.004 0.004 0.458 0.555 0.079 0.000 0.013 0.199 0.074 0.003 0.004 0.203
4 C 0.000 0.000 0.002 0.000 0.002 0.000 0.000 0.000 0.000 0.000 0.000 0.002 0.000
5 A/T 0.148 0.062 0.000 0.000 0.210 0.130 0.094 0.001 0.000 0.128 0.067 0.000 0.000
6 A/T 0.097 0.130 0.000 0.000 0.227 0.088 0.165 0.000 0.000 0.067 0.128 0.000 0.000
7 G 0.000 0.000 0.000 0.001 0.001 0.000 0.000 0.000 0.003 0.000 0.000 0.000 0.002
8 T/C 0.000 0.077 0.097 0.004 0.178 0.003 0.087 0.213 0.010 0.003 0.074 0.203 0.004
9 T/C 0.006 0.085 0.091 0.004 0.186 0.007 0.092 0.080 0.004 0.006 0.097 0.086 0.004
10 T/C 0.007 0.043 0.018 0.008 0.076 0.013 0.098 0.223 0.006 0.009 0.104 0.066 0.006
11 A/G 0.043 0.007 0.008 0.018 0.076 0.086 0.012 0.009 0.178 0.099 0.010 0.007 0.069
12 A/G 0.085 0.006 0.004 0.091 0.186 0.090 0.005 0.001 0.096 0.087 0.004 0.001 0.080
13 A/G 0.077 0.000 0.004 0.097 0.178 0.079 0.000 0.013 0.199 0.087 0.000 0.003 0.186
14 C 0.000 0.000 0.001 0.000 0.001 0.000 0.000 0.000 0.000 0.000 0.000 0.001 0.000
15 A/T 0.130 0.097 0.000 0.000 0.227 0.130 0.094 0.001 0.000 0.114 0.055 0.000 0.000
16 A/T 0.062 0.148 0.000 0.000 0.210 0.088 0.165 0.000 0.000 0.055 0.114 0.000 0.000
17 G 0.000 0.000 0.000 0.002 0.002 0.000 0.000 0.000 0.003 0.000 0.000 0.000 0.001
18 T/C 0.004 0.089 0.458 0.004 0.555 0.003 0.087 0.213 0.010 0.000 0.087 0.186 0.003
19 T/C 0.004 0.095 0.492 0.003 0.594 0.007 0.092 0.080 0.004 0.004 0.087 0.080 0.001
20 T/C 0.006 0.245 0.068 0.005 0.323 0.013 0.098 0.223 0.006 0.010 0.099 0.069 0.007
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p53REs are used to evaluate the quarter-site couplings.
RESULTS
Definitions and analysis of thesymmetry of p53REs
In the case of a perfect palindrome and two exact repeats,
the three symmetry elements are tangled together.
However, the deﬁnition of a consensus site based on
purine and pyrimidine bases provides suﬃcient variation
to diﬀerentiate between the three couplings, in addition to
the consensus rule not followed strictly in most p53REs.
Still,  25% of the bases are simultaneously coupled by the
three couplings (Figure 1c). In order to measure indepen-
dent coupling, we removed the overlapping counts in
the half-site palindrome, full-site palindrome and between
the two half-site repeats prior to the calculation of the
coupling frequencies.
With the terms deﬁned above, we examine the three
p53RE datasets (see Materials and Methods section) to
investigate the symmetric nature of p53RE. Dataset one is
compiled from known experimentally veriﬁed sequences.
Datasets two and three are from computationally identi-
ﬁed p53-responsive genes using p53MH (in the mouse and
human genomes, respectively) (14).
Couplings between two half-sites are not
random. Appendix lists the 100 experimentally veriﬁed
p53REs, compiled from (10–13). In Table 1, we report
counts of bases at each of the 20 positions, and the
sequence logo corresponding to the 100 p53REs of
Figure 2a. Most p53REs have no spacers between the
two half-sites (55 of 100), but about half of the p53REs
do have insertions with spacers ranging from 1 to 14
(Table 1). As can be seen from the sequence logo, the ﬁrst
half-site is slightly more conserved (Figure 2a).
As indicated in Table 1, considerable violations of the
consensus sequence rule exist. In a few cases, even the
most conserved C and G bases in positions 4, 7, 14 and
17 violate the consensus rule. Even though an insertion
in-between quarter-sites within the half-sites inactivates
the p53 binding with a designed DNA (25), we observe
at least three p53RE sequences with such violation (14-3-3
 , site 2, GTAGCA TT AGCCC AGACA TGTCC;
THBs2(4156): AGCCA G AGGCC AGAAAGTG
AGGCT TGCTC; THBs2(3530) AGACT TGCCT
GATTCT GGGCT GCC AGATT).
Figure 3a examines the percentage of bases involved
in the Q-coupling (within half-sites), H-coupling (across
half-sites) and T-coupling (between half-sites) in the
datasets of human p53REs. At ﬁrst glance, we can see
that positions 4, 7, 14 and 17, which are the conserved C,
G, C and G, respectively, satisfy all symmetry require-
ments, and thus have the highest possible frequencies
(100%). For the others, the percentages of the three
couplings ﬂuctuate  40%, which means that the average
palindromes have  4–5 inverted base pairs for each 20
base p53REs (a perfect one should have 10bp for 20-base
full site).
Among the base pairs involved in the H-couplings,
many are also involved simultaneously in the Q-coupling
within the half-site. If we remove the overlap counts
between the H-coupling and Q-coupling and only count
the bases with H-coupling, as shown in Table 2, still
 30% of the bases are inverted (coupled) bases across the
two half-sites. We further observe more H-couplings
(129694bp) than Q-couplings (127826bp) in the potential
human p53REs (258400bp). The propensity for a base
to have an H-coupling or Q-coupling depends on its
position in the full-site p53REs. As shown in Figure 3b,
H-couplings between quarter-site 1 (Q1) and quarter-site 4
(Q4) are preferred, while H-couplings between quarter-site
2 (Q2) and quarter-site 3 (Q3) are less preferred. Positions
9–12 are preferred to have Q-couplings.
On the other hand, mouse p53REs (173780bp) show
lower H-coupling (86848bp) than Q-coupling (87424bp).
There are two conserved features between the human
(Figure 3b) and mouse coupling patterns (Figure 3c): the
preference for Q-coupling in positions 9–12, and the
preference for H-coupling in positions 5, 6, 15 and 16.
A/T pairs in these positions have been noted as important
for p53 transactivation (10). Figure 3d presents the results
for the small dataset of experimentally veriﬁed p53REs.
a
b
c
Figure 2. Sequence logos for three datasets. (a) Native p53REs
(compiled in Appendix). (b) Artiﬁcial p53REs with strict consensus
distributions in artiﬁcial dataset 1. (c) Artiﬁcial p53REs dataset 2 with
overall base distributions identical to the dataset of native p53REs.
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of translational T-couplings (base repeat or degeneracy) is
also position dependent (Figure 4), with positions 1, 2, 19
and 20 having a lower tendency to repeat the same base,
and with the mouse p53REs showing a higher tendency to
have T-coupling.
In order to check the statistical signiﬁcance of these
results, we generated two artiﬁcial p53REs datasets
(Materials and Methods section), each with the same
number of sequences as the potential human p53REs
(25840). The ﬁrst artiﬁcial dataset strictly follows the con-
sensus rule, with the sequence logo shown in Figure 2b.
This dataset has  50% Q-couplings, H-couplings and
T-couplings at every position, indicating that a simple
consensus rule does not reﬂect the symmetry codes in
p53REs. The second artiﬁcial dataset has exactly the same
sequence logo as the human potential p53REs (Figure 2c).
Violations of the consensus decrease all three couplings
to a similar extent as in the potential human p53REs
(Figure 5a). However, in the artiﬁcial datasets, there are
random distributions for the Q-coupling and H-coupling
(Figure 5b). Therefore, the diﬀerence between the
Q-coupling and H-coupling in the datasets of potential
p53REs reﬂects the preferences to have Q-coupling within
the half-sites or to have H-coupling across the half-sites.
Base pair insertions between the two half-sites modulate
palindrome patterns of p53REs. Previously it was pro-
posed that the spacers between the two half-sites of
p53REs can range in size from 0 to 14nt. Recently, it was
observed that the length of the spacers is predominantly
zero, although there are p53REs with 1bp or longer
insertions (4). In the experimental dataset compiled in this
work,  46% of the p53REs have spacers. Here, we found
that base pair insertions between the two half-sites
modulate the repeat patterns of the p53REs, probably
reﬂecting the need to accommodate the geometrical
constraints in the binding of the p53 tetramer to such
p53REs.
Insertion of spacers between two half-sites modulates
the symmetry couplings in p53REs. We highlight
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Nucleic Acids Research, 2007, Vol. 35, No. 9 2991four groups of p53REs in Figure 6, showing the changes in
the diﬀerences between the two half-sites (H-couplings)
and within the half-sites (Q-couplings) with the number of
inserted base pairs (for 0, 3, 8 and 14 spacers). We also
report the changes of coupling with all insertions in
Supplementary Figures 1 and 2 for the human and mouse
genomes, respectively. In Figure 6a of human p53REs
without base pair insertions, we see the strongest pre-
ference for H-coupling. For the details of the coupling, in
Table 3 we list the fractions of bases involved only in
H-coupling. In position 2, 59.4% of the bases are coupled
only across the two half-sites, while 19.3% of the bases
are coupled only within the half-sites, leading to 40%
preference for a base pair to couple with another base pair
in the other half-site, over coupling with another base pair
in the same half-site (Figure 6a). Thus, in human p53RE,
quarter-sites 1 and 4 are correlated. Mouse p53REs
without insertions show a similar coupling pattern as in
human, although the preference for quarter-sites 1–4
correlation is not as strong (Figure 6b).
For both human and mouse p53REs, insertions of 1 or
2bp (Supplementary Figures 1 and 2) destroy the domi-
nancy of the quarter-sites 1–4 correlation, while the
A/T sites in the two half-sites are still preferred to be
coupled. On the other hand, insertion of 3bp appears
to reverse the coupling preferences (Figure 6 and
Supplementary Figures 1 and 2), and Q-couplings within
the half-site are dominant. Mouse homologs show asimilar
trend with a less pronounced change (Figure 6b). With
8-bp insertion, mouse p53REs show preferred Q-coupling
(Figure 6b). The H–Q coupling pattern for p53REs with
an 8-bp spacer for the mouse is similar to that of 3-bp
insertion for human. The signiﬁcance of insertions of 3-and
8-bp spacers is reﬂected in the coupling pattern, as well as
in their frequencies of occurrence, as indicatedin Figure 6c.
For the human p53REs, the top three frequencies are
no insertion, insertion of 3bp and insertion of 8bp
(Figure 6c). For the mouse p53REs, insertion of 8bp is
the most frequent (Figure 6c). Variation of sequence
patterns in promoter regions of diﬀerent species was
recently proposed to have been adopted by evolution to
modulate the regulation of gene expression (26).
Figures 6 and Supplementary Figures 1 and 2 indicate
that insertions modulate the p53REs’ correlations among
the four quarter-sites. Taking insertions of 4–7 and
10–14bp as examples, we see variability in the coupling
trends. Insertions of 10–13bp aﬀect the modulation to a
lesser extent. The preference for long-range quarter-sites
1–4 correlation appears to be restored with 14bp. Again,
the artiﬁcial p53RE dataset does not illustrate a variation
between the Q-coupling and H-coupling with insertion
length.
A/T bases in the WW region might signal a palindrome of
p53REs. Examination of Figure 6 reveals that positions 5,
6, 15 and 16 (A/T bases in the WW region) also have
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2992 Nucleic Acids Research, 2007, Vol. 35, No. 9diﬀerent H–Q coupling behavior with the spacer length.
Since each half-site has one of the four TA, TT, AT, AA
combinations, the two half-sites in the p53REs may have
16 possible combinations in the two WW regions. Figure 7
plots the frequencies for both human and mouse p53REs
divided into groups with various spacer lengths between
the two half-sites. The X-axis indicates combinations of
the two WW regions. For example, TA AA means
that the sequence in positions 5 and 6 is TA, and that in
position 15 and 16 is AA. Both human and mouse p53REs
show a similar pattern with certain frequently occurring
sequences for a given number of base pairs between the
half-sites. For the human p53REs, without insertions
between half-sites the most frequent sequence is AT AT.
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Nucleic Acids Research, 2007, Vol. 35, No. 9 2993For other spacer lengths, TT TT and AA AA have
frequent insertions of 4bp; TA AT and AT TA with
3-bp insertions.
The most noteworthy combination is AT AT in the
p53REs without a spacer. The signal of AT AT combi-
nation could promote H-coupling across the half-sites. As
can be seen in Figures 7a and c, the AT AT combination
is enriched by 47% in human p53REs without insertion.
This group has the strongest H-coupling between quarter-
sites Q1 and Q4. 80% of the sequences with AT AT
combinations show correlations at positions 2–19 and
3–18 (H-coupling), while these sites have little Q-coupling
(Figure 7c).
p53REs quarter-site couplingand experimental DNA–p53
tetrameraffinities
To probe the implications of the various couplings in each
position in p53REs, we look at the quarter-site couplings
by adding up the frequencies of Q-, H- and T-couplings in
the quarter-sites. There are at least ﬁve possible quarter-
site correlations. The ﬁrst is the half-site palindrome:
quarter-site one correlates with quarter-site two and
quarter-site three correlates with quarter-site four, which
we call Q1234. Since the correlation is within each half-
site, their frequencies are described by Q-coupling. The
rest are couplings across half-sites. Two are translational
repetitions, with T13 referring to the correlation of
quarter-site 1 and quarter-site 3 and T24 for quarter-
sites 2 and 4. The full-site palindrome of p53RE is evalu-
ated by two H-coupling correlations: H14 for quarter-sites
1 and 4 and H23 for quarter-sites 2 and 3.
The weights of ﬁve correlation modes are evaluated
as the sum of their corresponding quarter-site frequency
matrix described in the Materials and Methods section.
We show the frequencies of bases involved in the three
couplings in Table 3. Taking the human Puma-binding
site 2 (GGACAAGTCA GGACTTGCAG) as an example,
by adding up the weighted sequence-dependent matrix, we
can come up with the sum of the fractions Q1234¼0.599,
T13¼0.930, T24¼0.660, H14¼1.416 and H23¼0.559.
By converting the sum of fractions into percentages, the
ratios are 14.4, 22.3, 15.9, 34.0 and 13.4%, for the Q1234,
T13, T24, H14 and H23, respectively (Table 4).
Toinvestigateifthequarter-sitecouplingmodesencoded
in the p53REs correspond to p53–DNA interactions,
we compare the coupling mode populations with the
binding aﬃnities of p53 to various response elements.
Weinberg et al. (13) have systematically measured the
binding aﬃnities of a tetrameric p53 construct (residues
94–360) with 20 of its response elements from a variety
of representative genes. In Table 5, we compare the
computed populations for the ﬁve coupling modes with
experimental binding aﬃnities. We found no correlation
with experiment for the Q1234 mode (half-site palin-
drome), T13 mode and T24 mode. On the other hand, we
found that the full-site palindrome correlates with experi-
mental p53 aﬃnities. The correlation between H14 mode
with experiments was R
2¼0.23, and that between H23
mode with experiments was R
2¼0.36. Since there are
considerable variations in experimental aﬃnities, we
grouped the p53REs according to their binding aﬃnities
(very strong, strong, weak and very weak; Table 5). While
experimental aﬃnities show a clear division into distinct
(very strong, strong, weak and very weak) binding
aﬃnities, the number of p53REs that experiment observed
to fall into the ﬁrst category versus the other categories
varies substantially. We also noticed that the groupings
lead to only four data points. Using the average values
from these binding groups, we see that there are correla-
tions for modes H14 and H23 with experimental aﬃnities,
with R
2¼0.86 and 0.99, respectively (Figure 8). The
stronger is the H14 coupling and the weaker H23 coupling
mode, the higher the aﬃnity of the p53 tetramer with its
response element. This result suggests that the H14 mode
contributes the most to the observed p53 tetramer–DNA
interactions. Thus, full-site palindrome is important for
p53–DNA interactions.
Insertions between the two half-sites again modulate
the coupling mode distributions. We computed the popu-
lations of the ﬁve modes for all potential p53REs in the
mouse and human datasets obtained in p53MH. As can
be seen in Table 6, the H14 mode dominates the p53REs
without spacer. A single base pair insertion destroyed the
H14 dominance. The Q1234 quarter-site coupling is
mostly preferred with an insertion of a 3bp spacer for
the human genome and an insertion of an 8bp spacer
for the mouse genome, while it has the least probability
for the p53REs without spacer. The H23 coupling is dis-
favored when there is no spacer. For most spacer lengths,
there is a tendency for the T24 mode to dominate.
Table 4. Five p53REs and proposed p53 coupling modes examined by an empirical weighting matrix
Gene Sequence Q1234 T13 T24 H14 H23
p21-50 CTATGAG GAACATGTCC CAACATGTTG AGCTC Sum of fraction 0.657 0.786 0.912 0.742 0.618
Population% 17.69 21.16 24.54 19.96 16.64
Gad45A TGTACA GAACATGTCT AAGCATGCTG GGGTC Sum of fraction 0.821 0.983 0.912 1.110 0.698
Population% 18.15 21.73 20.14 24.55 15.43
pDINP1 TTTATA GAACTTGGGG GAACATGTTT ACCAA Sum of fraction 0.597 0.919 0.633 0.896 0.457
Population% 17.04 26.24 18.08 25.58 13.05
p53Aip TCCTCC TCTCTTGCCC GGGCTTGTCG AGATG Sum of fraction 0.624 0.674 1.024 0.814 0.642
Population% 16.52 17.83 27.11 21.54 17.0
Puma-BS2 TGCCGC GGACAAGTCA GGACTTGCAG GCGCG Sum of fraction 0.599 0.930 0.660 1.416 0.559
Population% 14.38 22.33 15.86 34.00 13.42
2994 Nucleic Acids Research, 2007, Vol. 35, No. 9p53REs quarter-site coupling andtranscriptional target
functions
In order to perform the complex gene regulation func-
tions, p53 needs to diﬀerentiate between hundreds
response elements. Thus, the symmetry information
encoded in the p53REs may relate to the functions of
the genes that p53 activates or represses. Based on the
speciﬁc experimentally observed p53 downstream eﬀects
(11) and on the p53 knowledge-base information resource
(12), we grouped the dataset of experimental veriﬁed
p53REs into several groups (Appendix): cell cycle control,
death receptor pathway of apoptosis, DNA repair,
apoptosis, positive regulation and negative regulation.
Two p53REs (TGFA) are related to growth control, and
PLK2 is related to mitosis. We also grouped the p53
human repressors to see whether there is a diﬀerence
between gene transactivation and repression. For each of
the experimental p53REs, we computed the quarter-site
coupling probabilities (Appendix).
In particular, we focus on the H14 and Q1234 cou-
plings in the ﬁve groups with suﬃcient entries (cell cycle,
apoptosis, positive regulation, negative regulation and
repressors). The full-site palindrome H14 coupling has
been shown to correlate with experimental p53-binding
aﬃnities in p53REs quarter-site coupling and experimental
DNA–p53 tetramer aﬃnities section and the Q1234
is a measure of the half-site palindrome. The average
H14 coupling for the cell cycle, apoptosis, positive
regulation, negative regulation and repressor groups are
0.28, 0.26, 0.32, 0.25, and 0.20, respectively. The average
Q1234 coupling is less sensitive to the function, 0.17, 0.17,
0.15, 0.19 and 0.20 for the cell cycle, apoptosis, positive
regulation, negative regulation and repressor groups,
respectively. Even though the cell cycle group has higher
average H14 couplings than the apoptosis group, both
groups have large variations and have mixed strong and
weak H14 couplings. But the H14 couplings in the groups
of positive regulation, negative regulation and repressor
are clearly diﬀerent. Most p53REs in the positive regula-
tion group (except RGC) have strong H14 coupling
(average value 0.32). The negatively regulated group is
dominated by p53REs with weak H14 couplings (average
value 0.25). The human p53 repressor group genes have the
weakest H14 coupling (average value 0.20), suggesting that
p53 may activate and repress genes using diﬀerent
mechanisms. The weak H14 couplings in the repressor
group results mostly from insertion of spacers; however, it
is interesting to see that p22 also has a weak H14 coupling
even though its response element has no spacer, suggesting
a possible intrinsic requirement for p53-repressed genes.
However, additional data is needed to support this
conclusion.
DISCUSSION AND CONCLUSIONS
The information encoded in the p53RE is a combination
of the half-site palindrome, repeat and the full-site
palindrome. This raises the question of which are the
dominant coupled elements. Linkage of the two half-sites
leads to a full-site palindrome, determining the overall
properties of the p53RE. Palindromic DNA sequences
have been found to be enriched in binding sites for
transcription factors (27,28), since a palindrome increases
the productive encounters between transcription factors
Table 5. Comparison of computational quarter-site coupling probability and experimental p53–DNA aﬃnity
Group P53REs Q1234 T13 T24 H14 H23 Kd (nM)
a
Very strong binding 14-3-3   s1 13 13.4 20.8 44.7 8.1 9.9 2.1
14-3-3   s2 16.1 16.7 23.6 30.5 13.1 10 2.1
GADD45 18.1 21.7 20.1 24.5 15.4 7.7 1.2
Maspin 18.9 18.4 22.2 22.4 18.1 9.2 1.7
MDM2 13.7 21.8 16.5 33.6 14.4 12.3 2.9
NOXA 16.3 18.8 19.9 31.3 13.8 8.6 1.6
P21-50 site 17.7 21.2 24.5 20 16.6 4.9 0.6
P21-30 site 16.3 24.3 15.8 30.9 12.8 12 7.0
P53AIP1 16.5 17.8 27.1 21.5 17 11.0 1.8
P53R2 15.9 16 21.6 33.1 13.5 5.7 0.8
PCNA 17.1 26.2 20.2 21.5 15.1 6.6 1.4
PIDD 19 17.2 23.9 19.8 20.1 14.7 5.0
PUMA-BS2 14.4 14.7 24.5 33.3 13.1 7.1 1.8
Cyclin G 14.5 15.4 20.8 37.3 12 7.8 1.6
Group average 16.3 18.8 21.6 28.9 14.5 9.1
Strong binding KAI 1 18.9 19 22 24.7 15.4 33 10.9
Group average 18.9 19 22 24.7 15.4 33 10.9
Weak binding Bax 18.9 18.1 22.1 19 21.8 73 33
IGF-BP3 box A 18.6 18.8 21.8 23 17.7 81 25
P53DINP1 17 26.2 18.1 25.6 13 98 23
Group average 18.2 21 20.7 22.5 17.5 84
Very weak binding P2XM 18.7 21.3 19 24.3 16.7 221 41
PUMA-BS1 18.2 15.9 26.4 12.6 26.9 260 50
Group average 18.5 18.6 22.7 18.5 21.8 241
aReference (13).
Nucleic Acids Research, 2007, Vol. 35, No. 9 2995and DNA (27). One example with a comparable 20bp
palindrome is the T-box genes (29), also with various
possible combinations (21). Even though two-palindrome
repeats may be characteristic of p53REs, the higher order
palindrome in the full-site p53REs highlights the overall
consistency of the p53REs with other transcriptional
factors. The multiple-palindromic feature of the p53REs
may be an elegant way to ensure the overall full-site
palindrome, beyond two half-sites. In many cases, natural
p53REs have more than two half-sites, yet still main-
taining the internal symmetry (18).
The contribution of the coupling between the two half-
sites to p53–DNA interactions may explain the coopera-
tive nature of the p53 tetramer–DNA binding. It is well
known that p53 dimer–DNA interaction is weak while
tetramerization enhances p53-binding aﬃnity signiﬁcantly
(13,30). In the present study, we have shown that coupling
between quarter-sites one and four, which are distant from
each other, may be responsible for the increase in the
p53-binding aﬃnity upon tetramerization. On the other
hand, the adjoining H23 coupling appears to decrease
p53-binding aﬃnity.
The correlation between DNA-encoded symmetry
information and protein interaction reﬂects a DNA-
centric look at protein–DNA complexes. Statistical
analysis of protein–protein interactions has revealed
protein–protein interaction hot spots (31), which are also
important for the interaction of p53 with other cellular
proteins (32,33). Here, we noticed ‘hot spot’-like couplings
between positions 2 and 19 in p53REs, located in quarter-
sites one and four, respectively.
The variations in H14 coupling are also consistent
with several other observations related to p53’s transacti-
vation activity. We have shown in base-pair insertions
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2996 Nucleic Acids Research, 2007, Vol. 35, No. 9between the two half-sites modulate palindrome patterns
of p53REs section that positive H14 coupling is enhanced
when there are two CATG sequences at the half-sites.
Indeed, in their study of native p53 genes, Inga et al. also
noticed that p53REs with the two CATG sequences have
the strongest transactivation of p21-50, p53R2, m-FAS
and GADD45 and conﬁrmed the trend in their designed
artiﬁcial sequences (10). Further, in the p53MH database
that we have used, while the group of p53REs without
spacers occurs most frequently, there was also a sizeable
population of p53REs with spacers (Figure 6c). On the
other hand, using chromatin immunoprecipitation (ChIP)
and paired-end ditag (PET) sequencing strategy, Wei et al.
searched for p53 targets in the human genome, observing
that 83% (236 of 284) of the motifs had no spacer (4).
The enrichment of H14 coupling in the group of p53REs
without insertions may explain this preference.
The binding of p53 to its target DNA presents a geo-
metric problem: p53REs may have insertions of variable
lengths between the half-site palindromes or they may
not have base-pair insertions. Further, p53 has also been
shown to bind to three-way and four-way Holliday
junctions (34). The question arises as to how p53 is able
to bind such a broad spectrum of targets. It is unclear just
how would p53 recognize DNA sequence speciﬁcally
and at the same time recognize diﬀerent geometries with
sequence variability as in the case of the four-way
Holliday junction, where two DNA molecules exchange
strands (35). Strong binding of p53 to the Holliday and
to three-way junctions appears to rely on the p53 core
domain with further stabilization of the p53–DNA
junction complex by the tetramerization domain (3).
Here, we hypothesize that if there are multiple binding
modes of the p53 tetramer with the DNA, the palindrome
symmetries encoded in p53REs (with and without inser-
tions) may provide some clues. The correlation of quarter-
sites one and four is particularly interesting. The
structures of the p53 dimer symmetrically positioned on
the DNA half-site may explain both the half-site
palindrome and the full-site palindrome. On the other
hand, the asymmetric p53 dimer DNA recognition in the
p53 trimer–DNA complex can discriminate between the
half-site and the full-site palindrome. Alternatively,
variations of the symmetric positioning such as rotations
and shifts may optimize the p53–p53RE interactions
accommodating such cases. Additional work is needed
to correlate the symmetry information encoded in p53REs
with structural features of p53–DNA recognition.
Our results are consistent with available experimental
data. In the currently available validated p53REs, most
have no spacers. Among those that have spacers, the most
frequent spaces that we observe are 3bp in length. The
dominant coupling that we observe for p53REs without
spacers is between quarter-sites one and four. Spacers
Table 6. Quarter-site coupling mode change for human and mouse p53RE with various spacers
Number of spacer Q1234 T13 T24 H14 H23 Correlation (R
2)
0 Human 14.99 17.18 19.67 36.99 11.17 0.8871
Mouse 17.88 18.28 22.40 26.37 15.06
1 H 18.68 18.32 22.77 19.93 20.30 0.000
M 20.91 20.84 20.67 16.9 20.68
2 H 18.54 18.58 21.77 20.35 20.75 0.5725
M 18.39 19.93 22.20 20.03 19.45
3 H 29.80 18.08 20.15 17.60 14.36 0.0696 (0.3968)
a
M 20.02 20.71 20.23 19.66 19.38
4 H 17.94 19.77 22.52 20.92 18.86 0.3468
M 13.90 27.77 28.40 14.10 15.84
5 H 18.8 19.58 22.23 19.68 19.71 0.7523
M 18.26 19.87 21.72 19.39 20.76
6 H 17.96 18.47 23.49 20.04 20.03 0.0142
M 19.94 21.40 20.95 19.13 18.60
7 H 19.28 18.83 21.30 18.23 22.36 0.0017
M 19.03 20.67 20.75 20.01 19.54
8 H 18.14 18.93 22.50 20.42 20.02 0.0031 (0.3968)
a
M 24.37 15.39 20.20 15.86 21.07
9 H 19.57 18.77 21.33 20.61 19.72 0.6537
M 19.02 19.42 21.51 19.90 20.15
10 H 18.12 19.96 22.63 19.35 20.95 0.5816
M 18.76 18.79 24.18 19.90 18.75
11 H 18.47 20.30 21.72 19.21 20.31 0.2669
M 19.30 17.84 22.59 20.46 19.78
12 H 18.61 19.06 21.85 19.78 20.70 0.7691
M 19.10 18.06 22.7 18.13 21.20
13 H 18.78 18.91 21.45 20.24 20.62 0.4743
M 18.43 20.35 21.95 19.60 19.67
14 H 18.23 16.95 21.90 24.85 18.06 0.735
M 18.80 18.80 22.22 21.31 18.89
aThe correlation coeﬃcient of human p53REs with 3bp spacer and mouse p53REs with 8bp spacer is R
2¼0.3968
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to a lesser extent 8bp strengthening the most the coupling
between quarter-sites one and two.
Insertions of a few base pairs are expected to present
geometric problems to the p53 tetramer interaction with
the DNA, possibly relating to the shift in the dominance
of the coupling mode. How do the spacer sizes relate to
the actual interaction and the details of the structure
of the tetrameric p53–DNA complex with diﬀerent spacer
lengths is a challenging problem. In principle, binding
modes may diﬀer from each other to various extents,
ranging from minor adjustments, to rotational motions to
accommodate the supercoiled DNA with diﬀerent faces
presented to the p53, to more substantial conformational
diversity.
The observations made on the mouse genome show
consistency and variation compared with those made
on the human genome. For p53REs with insertions, the
couplings between quarter-sites one and four (H14) are
less pronounced than those observed in human analogs.
While insertion of 3bp highlights the half-site palindrome
in the human genome, in the mouse genome insertion of
an 8bp spacer leads to such an eﬀect. This apparent
diﬀerence in the distributions between the human and
mouse genomes may reﬂect adjustment by evolution,
probably reﬂecting the underlying diﬀerence in the p53
interaction networks in human and mouse. Although why
and how it is actually reﬂected in the binding remains to
be elucidated, it can be inferred that the binding modes in
the mouse genome have more of the half-site palindrome
character and are more consistent with symmetrical p53
tetramer DNA binding, while the binding modes with
preferred H14 coupling may have more signiﬁcance in
human genome. Our results further suggest that the
binding modes involved in p53 recognition of positively
and negatively regulated genes could be diﬀerent. The
weak H14 coupling in the p53-repressed genes appears to
distinguish between the mechanisms of gene repression
and activation.
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APPENDIX
Dataset of experimental veriﬁed p53 response elements
Trarget gene and
binding site
DNA sequence Quarter-site coupling probability Reference
Cell cycle Q1234 T13 T24 H14 H23
14-3-3  -site 2 GTAGCA tt AGCCC AGACA TGTCC 0.13 0.13 0.21 0.45 0.08 (10,11,13) SFN in (12)
14-3-3   -site 1 AGGCA TGTGC CACCA TGCCC 0.16 0.17 0.24 0.31 0.13 (11,13)
B99 GAGCA AGTTG GGGCT TGCCT 0.15 0.21 0.15 0.39 0.10 (11)
Cyclin G AGACC TGCCC GGGCA AGCCT 0.15 0.15 0.21 0.37 0.12 (10,13)
Cyclin G,C AGGCT TGCCC GGGCA GGTCT 0.15 0.19 0.17 0.37 0.12 (10)
BTG2 AGTCC GGGCA g AGCCC GAGCA 0.21 0.22 0.17 0.19 0.22 (12)
gml ATGCT TGCCC AGGCA TGTCC 0.16 0.17 0.24 0.30 0.13 (12)
p21-50 site GAACA TGTCC CAACA TGTTG 0.18 0.21 0.25 0.20 0.17 (11,13)
p21-30 GAAGA AGACT GGGCA TGTCT 0.16 0.24 0.16 0.31 0.13 (13)
CDKN1a GAACA TGTCC CAACA TGTTG 0.18 0.21 0.25 0.20 0.17 (12)
GDF CATCT TGCCC AGACT TGTCT 0.16 0.13 0.27 0.28 0.16 (12); PTGF-b, FBS01 in (11)
GDF AGCCA TGCCC GGGCA AGAAC 0.16 0.21 0.23 0.24 0.16 (12); PTGF-b, SBS01 in (11)
RB GGGCG TGCCC cgc GTGCG CGCGC 0.25 0.17 0.22 0.17 0.18 (11)
CCNG1 GCACA AGCCC AGGCT AGTCC 0.16 0.20 0.25 0.24 0.15 (12) (cyclin, human)
PCBB4 GGTCT TGGCC ca GACTT AGCAC 0.18 0.19 0.21 0.19 0.22 (12)
Average 0.17 0.19 0.21 0.28 0.15
Standard deviation 0.03 0.03 0.04 0.08 0.04
Growth
TGFA AGCCA AGTCT TGGCA AGCGG 0.16 0.18 0.16 0.34 0.15 (12)
TGFA GGGCA GGCCC TGCCT AGTCT 0.14 0.17 0.18 0.43 0.09 (12) TGF a in (11)
Average 0.15 0.18 0.17 0.39 0.12
Death receptor
m-FAS GGGCA TGTAC AAACA TGTCA 0.14 0.20 0.17 0.38 0.11 (10); Fas(APO-
1/CD95), in (11)
TNFRSF GGGCA TGTCC GGGCA AGACG 0.14 0.24 0.15 0.34 0.13 (12); Killer/DRS in (11)
PIDD AGGCC TGCCT gcgtgctg
GGACA AGTCT
0.19 0.17 0.24 0.20 0.20 (13) PIDD in (11)
LRDD in (12)
H-FAS,A TGGCT TGTCA GGGCT TGTCC 0.14 0.19 0.18 0.36 0.12 (10)
Average 0.15 0.20 0.18 0.32 0.14
Standard deviation 0.02 0.03 0.04 0.08 0.04
DNA repair
GADD45A GAACA TGTCT AAGCA TGCTG 0.18 0.22 0.20 0.25 0.15 (10–13)
rrm2b (p53R2) TGACA TGCCC AGGCA TGTCT 0.16 0.16 0.22 0.33 0.14 (10–13)
PCNA ACATA TGCCC GGACT TGTTC 0.17 0.26 0.20 0.22 0.15 (12)
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Trarget gene and
binding site
DNA sequence Quarter-site coupling probability Reference
Q1234 T13 T24 H14 H23
Pcna GAACA AGTCC GGGCA TATGT 0.17 0.18 0.30 0.21 0.15 (10–13)
Average 0.17 0.20 0.23 0.25 0.15
Standard deviation 0.01 0.06 0.05 0.06 0.01
Apoptosis
Bax-A TCACA AGTTA g AGACA AGCCT 0.19 0.18 0.22 0.19 0.22 (10–12)
BAX-B,A AGACA AGCCT GGGCG TGGGC 0.17 0.21 0.21 0.29 0.13 (10)
BAX-mouse AGGCA AGCTT t GAACT TGCGG 0.19 0.21 0.20 0.19 0.22 (24)
BAX-human GGGCA GGCCC GGGCT TGTCG 0.15 0.23 0.17 0.37 0.10 (24)
IRDD AAGCT GGGCC GGGCT GACCC 0.14 0.21 0.17 0.39 0.09 (12) Cathepsin D
site 1, (11)
IRDD AACCT TGGTT tg CAAGA GGCTT 0.19 0.19 0.22 0.19 0.22 (11)
ei24/PIG8 TGGCA GGCCG GAGCT AGTTC 0.16 0.23 0.18 0.32 0.11 (11)
IGFBP3A,A AAACA AGCCA c CAACA TGCTT 0.19 0.19 0.22 0.23 0.18 (10–13)
IGFBP3 B,A GGGCA AGACC TGCCA AGCCT 0.13 0.16 0.17 0.46 0.08 (12) IGF-BP3,
Box B in (11)
MCG10, RE-1 GGTCT TGGCC ca GACTT AGCAC 0.18 0.19 0.21 0.19 0.22 (11)
MCG10, RE-1
(PCBB4)
GAACT TAAGA ccgaggctct
GGACA AGTTG
0.18 0.24 0.17 0.21 0.20 (12)
NOXA AGGCT TGCCC CGGCA AGTTG 0.16 0.19 0.20 0.31 0.14 (10,11,13)
p53aip1 TCTCT TGCCC GGGCT TGTCG 0.17 0.18 0.27 0.22 0.17 (12,13)
PERP, 218 GCTCA AGTGT agcctt AGCCA TGCTC 0.18 0.19 0.23 0.17 0.23 (11)
PERP, 2097 GCGCT AGTCC acac AGACT AGATT 0.18 0.17 0.25 0.20 0.19 (11)
TP5313 CAGCT TGCCC ACCCA TGCTC 0.16 0.13 0.30 0.30 0.11 (12) PIG3 in (11)
bbc3 (puma-bs2) CTGCA AGTCC TGACT TGTCC 0.14 0.15 0.25 0.33 0.13 (12,13)
PUMA-BS1 CTCCT TGCCT t GGGCT AGGCC 0.18 0.16 0.26 0.13 0.27 (13)
pDINP1 GAACT TGGGG GAACA TGTTT 0.17 0.26 0.18 0.26 0.13 (13)
p2rx (P2XM) GAACA AGGGC at GAGCT TGTCT 0.19 0.21 0.19 0.24 0.17 (11–13)
Ctsd AACCT TGGTT tg CAAGA GGCTT 0.19 0.19 0.22 0.19 0.22 (12)
cFOS,O AGGCT TGCCC CGGCA AGTTG 0.16 0.19 0.20 0.31 0.34 (10)
fas GGACA AGCCC TGACA AGCCA 0.14 0.16 0.20 0.37 0.12 (12)
Average 0.17 0.19 0.21 0.26 0.16
Standard deviation 0.02 0.03 0.03 0.08 0.05
Positive regulation
SCARA GGGCA AGCCC AGACA AGTTG 0.16 0.21 0.19 0.30 0.14 (12). CSR in(11)
mdm2 AGTTA AGTCC TGACT TGTCT 0.14 0.22 0.17 0.34 0.14 (12)
MDM2-RE2 GAGCT a AGTCC TGACA TGTCT 0.14 0.13 0.20 0.41 0.12 (10)
mdm2 GGTCA AGTTG GGACA CGTTC 0.15 0.19 0.19 0.35 0.13 (13)
mdr1b GAACA TGTAG AGACA TGTCT 0.16 0.21 0.17 0.33 0.14 (11)
PA26 GGACA AGTCT CCACA AGTTC 0.16 0.19 0.22 0.29 0.14 (11)
PA26,C GGACA TGTCT CAACA AGTTC 0.16 0.19 0.22 0.27 0.16 (10)
RGC,O GGACT TGCCT GGCCT TGCCT 0.14 0.16 0.21 0.39 0.11 (10)
RGC TGCCT TGCCT ggact
TGCCT GGCCT TGCCT
0.18 0.15 0.28 0.19 0.20 (11)
S100A2 GGGCA TGTGT GGGCA CGTTC 0.16 0.26 0.16 0.30 0.13 (12)
mmP2 AGACA AGCCT GAACT TGTCT 0.15 0.16 0.18 0.39 0.12 (12); Type IV
Collagenase (11)
Average 0.01 0.04 0.03 0.06 0.02
Standard deviation 0.17 0.21 0.23 0.22 0.17
Negative regulation
Bdk GGAAG TGCCC AGGAG GCTGA 0.17 0.21 0.23 0.22 0.17 (12), BK2 in (11)
GPX GGGCC AGACC AGACA TGCCT 0.13 0.16 0.18 0.43 0.10 (11)
cFOS,O GGACT TGTCT GAGCG CGTGC 0.16 0.25 0.20 0.24 0.15 (10)
Met GGACG GACAG cacgcgaggcagac
AGACA CGTGC
0.19 0.26 0.10 0.29 0.16 (12)
Cytokeratin 8 CCGCC TGCCT cc ACTCC TGCCT 0.18 0.07 0.35 0.20 0.20 (11)
Dickkopf-1 AGCCA AGCCT ttaatg AACCA AGTTC 0.19 0.17 0.24 0.20 0.21 (11)
EEf1A1 GGGCA GACCC ga GAGCA TGCCC 0.19 0.21 0.19 0.22 0.19 (12) EF-1 a E4 in (11)
EEf1A1 GGACA CGTAG attc GGGCA AGTCC 0.19 0.22 0.19 0.19 0.21 (12); EF-1 a, E2 in (11)
EEf1A1 AAACA TGATT ac AGGGA CATCT 0.18 0.25 0.16 0.25 0.16 EF-1 a E3 in (11)
EGFR GAGCT AGACG tcc GGGCA GCCCC 0.31 0.22 0.14 0.19 0.15 (12)
CX3 (Fractalkine) GGGCA TGTTC c CAGCT TGTGG 0.18 0.20 0.21 0.20 0.21 (11,12)
HGF ACACA TGTAT ttt CCTGT TTAAA 0.29 0.18 0.23 0.18 0.13 (11,12)
HIC-1 GGTCT TGTGC ag AGGCA TGTGC 0.19 0.20 0.20 0.18 0.24 (11)
M-PGAM TGCCA CTGGT TGCCT GCCTC TGCCT 0.14 0.10 0.24 0.43 0.08 (11)
(continued)
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Trarget gene and
binding site
DNA sequence Quarter-site coupling probability Reference
Q1234 T13 T24 H14 H23
MCK GGGCC TGCCT CTCTC TGCCT 0.14 0.10 0.22 0.47 0.08 (11)
SERPine1 ACACA TGCCT CAGCA AGTCC 0.17 0.17 0.24 0.27 0.16 (12) PAI-1 in (11)
Sgk AACTC AGGCT gcctcctg CGACT TGCCT 0.21 0.16 0.29 0.20 0.14 (11)
sm a actin AACCA TGCCT GCATC TGCCT 0.16 0.12 0.24 0.39 0.10 (11)
TAP1 GGGCT TGGCC ctgccg GGACT TGCCT 0.18 0.20 0.23 0.21 0.18 (11,12)
THBs2 AGCCA g AGGCC agaaagtg AGGCT TGCTC 0.20 0.22 0.21 0.19 0.18 (12); THBS2, 4156 in (11)
THBs2 AGACT TGCCT gattct GGGCT gcc AGATT 0.18 0.20 0.23 0.19 0.21 (12); THBS2, 3530 in (11)
TIMP-3 GGGCT TGCTT gacgtcca GAACA GGGTC 0.19 0.22 0.18 0.17 0.25 (11)
SERPI (Maspin) GAACA TGTTG g AGGCC TTTTT 0.189 0.184 0.222 0.224 0.181 (11–13)
cds2 AGGCA AGCTG gggca GCTCA AGCCT 0.189 0.19 0.22 0.247 0.154 (12) KAI1 in (11,13)
Average 0.19 0.19 0.21 0.25 0.17
Standard deviation 0.04 0.05 0.05 0.09 0.05
Mitosis
PLK2 GGTCA TGATT cct TAACT TGCCT 0.31 0.23 0.14 0.19 0.13 (12)
PLK2 AAACA TGCCT GGACT TGCCC 0.18 0.18 0.27 0.38 0.14 (12)
PLK2 AGACA TGGTG tgt AAACT AGCTT 0.30 0.17 0.19 0.21 0.13 (12)
Average 0.26 0.19 0.20 0.26 0.13
Human Repressor
TRPM GGCCT TGCCT tgctc AGGCC TGCTT 0.19 0.16 0.27 0.19 0.19 (12)
TRPM TGCCT TGCTC AGGCC TGCTT 0.16 0.13 0.27 0.32 0.12 (12)
TRPM GAGCA GGTCT
gacctgcttccca GGGCC TGCTT
0.19 0.19 0.23 0.24 0.16 (12)
TRPM TGACC TGCTT ccca GGGCC TGCTT 0.18 0.14 0.29 0.20 0.19 (12)
ODC1 GGGCT CGCCT tggtacagac GAGCG GGCCC 0.18 0.22 0.20 0.21 0.19 (12)
ODC1 GGACC AGTTC caggc GGGCG AGACC 0.19 0.19 0.23 0.18 0.22 (12)
CRYZ CTGCA AGTCC att AAACC TGTTT 0.27 0.15 0.26 0.17 0.14 (12)
slc38 AACCA TGCTG ttacacgcac CAGCT TGTCC 0.18 0.18 0.24 0.20 0.19 (12)
p22/PRG1 CCACA TGCCT CGACA TGTGC 0.19 0.16 0.30 0.16 0.19 (11), IER3 in(12)
ANLN GAACT GGCTT ttctga GGGCC AGGCC 0.17 0.21 0.21 0.22 0.19 (12)
scd GGGCC GGTCC t GGGCT AGGCT 0.19 0.21 0.21 0.18 0.22 (12)
Hspa8 GCACT AGTTC tggacctc GCGCG TGCTT 0.18 0.14 0.28 0.22 0.18 (12)
NOS3 GAGCC TCCCA gcc GGGCT TGTTC 0.28 0.16 0.25 0.17 0.15 (12)
CDC25C GGGCA AGTCT taccatttcca GAGCA AGCAC 0.18 0.23 0.19 0.18 0.22 (12)
Average 0.19 0.18 0.25 0.20 0.18
Standard deviation 0.03 0.03 0.03 0.04 0.03
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